Monday, October 8, 2018

Perimenopause & the Adrenal Connection

Last weekend I attended a seminar on understanding the rise and fall of hormones during perimenopause presented by Annette Kutz Schippel, DC. She practices nutrition and chiropractic in Illinois, specializing in women’s issues and pediatrics.

This is the third seminar I have taken with her. Her style is casual and easy going but she has a wealth of knowledge. This class completes my continuing education requirements for 2018 as a diplomate in nutrition. I have the choice of attending a couple of classes each year or presenting a paper for publication. Although I enjoy the challenge of writing, especially when it has to meet the requirements of peer review, I never seem to find the time.

I’ve attended several seminars on women’s health issues, particularly on menopause. However, this is the first that focused on perimenopause and, no pun intended, it did really fill in a gap.

As women enter perimenopause, hormone levels begin to fluctuate outside the normal ovulation cycle. This transition typically begins 2-3 years prior to menopause, but can start as much as 8-10 years before true menopause. By definition, menopause officially begins after menstruation has ceased for a full year.

During this transition women often experience heavier than normal bleeding, irregularity of the cycle, insomnia, depression, mood swings, weight gain, menstrual migraines, decreased fertility, decreased libido, bladder problems, fatigue, hot flashes, vaginal dryness, and more frequent illness.

Common treatment options are oral birth control, often prescribed to be taken continuously, progestin therapy, endometrial ablation surgery, bioidentical hormone treatment, partial or complete hysterectomy and/or increased use of anti-anxiety and anti-depressant medications.

Stress plays a large role in the severity of symptoms and typically the more severe the symptoms of perimenopause, the more severe her symptoms will be during menopause. This is because the adrenal glands, your organs that respond to stress, now have the additional burden of trying to make up for declining hormone production from the ovaries.

Friday, October 5, 2018

Can some foods reduce estrogen in men?

Estrogen and testosterone are hormones that occur naturally in male and female bodies. Some research suggests that certain foods can influence the levels of these hormones.

A 2016 study reports that testosterone levels decline by 0.4-2.0% each year after the age of 30. In some men, this decline leads to depression, reduced libido, erectile dysfunction, and low energy. When a man has a low level of testosterone, a doctor may recommend testosterone injections.

Estrogen is [also] vital for men’s health. It supports the functioning of almost every area of the body, including the brain, heart, bones, muscles, and the immune system. However, if a man’s estrogen levels are too high, this can cause a number of health problems, including obesity and depression.

A handful of studies have suggested that specific foods can raise or lower estrogen levels. However, scant evidence suggests that these foods can address the health effects of high estrogen. Some research suggests that the naturally occurring estrogens in plants, for example, do not affect levels of the hormone in male bodies. The research that suggests certain foods may be able to diminish the level of estrogen is often low-quality or has involved animals rather than humans.

Soy-based products, including edamame and some meat substitutes, are especially rich in plant estrogens. These phytoestrogens are weaker than estrogens that the body produces. When plant estrogens enter the body’s cells, they push out the body’s own estrogens. In this way, consuming more phytoestrogens could lower a person’s estrogen level.

Cruciferous vegetables also contain high levels of phytoestrogens and isoflavones. Results of several studies suggest that isoflavones may prevent the body from converting testosterone to estrogen.

Wednesday, October 3, 2018

Wisdom Wednesday: Does Glucosamine Work?


Glucosamine is a naturally occurring compound that is chemically classified as an amino sugar. It serves as a building block for a variety of functional molecules in your body but is primarily recognized for developing and maintaining cartilage within your joints.

Some studies indicate that supplemental glucosamine may protect joint tissue by preventing the breakdown of cartilage. One small study in 41 cyclists found that supplementing with up to 3 grams of glucosamine daily reduce collagen degradation in the knees by 27% compared to 8% in the placebo group. Another small study found a significantly reduced ratio of collagen-breakdown to collagen-synthesis markers in articular joints of soccer players treated with 3 grams of glucosamine daily over a three-month period.

Multiple studies indicate that supplementing daily with glucosamine sulfate may offer effective, long-term treatment for osteoarthritis by providing a significant reduction in pain, maintenance of joint space and overall slowing of disease progression.

Some studies have revealed significantly reduced markers of rheumatoid arthritis (RA) in mice treated with various forms of glucosamine. Conversely, one human study didn’t show any major changes in RA progression with the use of glucosamine. However, study participants reported significantly improved symptom management.

Monday, October 1, 2018

How cannabinoid drugs affect the experience of pain

A first-of-its-kind meta-analysis of existing research has reviewed the effects of cannabinoid drugs on the experience of pain.

The Centers of Disease Control and Prevention (CDC) suggest that up to 50 million people in the United States have chronic pain. An increasing amount of people now turn to the medicinal benefits of cannabis for treating and alleviating pain. As a result, scientists are trying to keep up by studying the effects of cannabinoids on pain. So far, however, studies have produced mixed results. A recent study that spanned over 4 years found “no evidence” that cannabis alleviates chronic pain that is not associated with cancer.

New research puts forth an interesting explanation for why the current clinical evidence does not fully support the popularity of cannabis as a painkiller and people’s subjective accounts of its benefits. It may be that the “feel-good” factor in the use of cannabis and cannabinoid drugs makes pain “more tolerable” and “less unpleasant,” suggests the new study, and that the benefits of cannabinoid drugs may operate more on an affective level rather than a sensory one.

To help clarify the analgesic properties, Martin De vita, a doctoral researcher at Syracuse University and colleagues examined over 1,830 experimental studies on the effects of cannabinoids that were carried out over a 40-year period. The study was recently published in the journal JAMA Psychiatry.

The results revealed that cannabinoid drugs correlated with “modest increases in experimental pain threshold and tolerance,” and a reduction in the “perceived unpleasantness of painful stimuli.”